Reveal Linq
Payments companies reported to CMS as associated with Reveal Linq. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Reveal Linq, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Reveal Linq
These are the largest totals companies reported as associated with Reveal Linq. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Rose | Tampa, FL | Neurology (Psychiatry & Neurology) | $6,240.40 |
| Vivek Rai | Columbus, OH | Vascular Neurology | $1,800.00 |
| Jane Rainsford | Clearwater, FL | Nurse Practitioner | $1,376.76 |
| Rami Kahwash | Columbus, OH | Advanced Heart Failure and Transplant Cardiology | $1,330.40 |
| Frederick Chaleff | Plantation, FL | Cardiovascular Disease | $918.10 |
| Adam Bierzynski | New York, NY | Internal Medicine | $910.60 |
| Pablo Urbandt | Plantation, FL | Cardiovascular Disease | $910.58 |
| Hetal Bhakta | Palm Springs, CA | Clinical Cardiac Electrophysiology | $859.13 |
| James Ong | Tarzana, CA | $844.36 | |
| Sitaramesh Emani | Cincinnati, OH | Advanced Heart Failure and Transplant Cardiology | $838.59 |
Prescribed Reveal Linq?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.